tirzepatide in uganda MHRA grants authorisation for Lilly's weight loss drug Mounjaro Tirzepatide Weight Loss Injections &

How glycine compares to other additives Not every compounding pharmacy uses glycine alone

A retrospective study of 51 cases

Gamma-glutamyl transferase variability and the risk of hospitalisation for heart failure

Health Canada announced Monday that it has authorized Svemia, a once-weekly semaglutide injection made by Canadian pharmaceutical company Apotex, for chronic weight management in people aged 12 and older as a supplement to a reduced-calorie diet and increased physical activity for chronic weight management. The approval marks the first generic semaglutide injection authorized in Canada for weight loss

Consumers are increasingly proactive about incorporating practices and products that help them maintain mobility and strength into later stages of life

Importantly, this benefit was across multiple organ system outcomes as shown below (no effect seen for reducing liver disease or diabetes)